PPT Slide

Westland et al., 37th Annual Meeting of the European Association for the Study of Liver

Diseases, Madrid, Spain, 17-21 April 2002. Oral presentation 568.

Study 461

• HBV isolates were sequenced at baseline, week 16 and
  week 32

LAM-Resistance

Mutations: rtV173L rtL180M rtM204V or I *

(521) (528) (552)

YMDD

C

B

A

D

E

Region Sequenced

Adefovir dipivoxil in lamivudine-resistant hepatitis B patients –

Study 461

Analyses of YMDD mutations

Previous slide

Next slide

Back to first slide

View graphic version